Last reviewed · How we verify

NCT02909608

Actigraphy in Pediatric Pulmonary Hypertension

Completed Last updated 7 June 2021
What this trial tests

trial testing No interventions / observations only in Pediatric Pulmonary Hypertension in 116 participants. Completed in 2 April 2020.

Timeline
7 October 2016
Primary endpoint
31 March 2020
2 April 2020

Quick facts

Lead sponsorUniversity of Colorado, Denver
StatusCompleted
Study typeOBSERVATIONAL
Enrollment116
Start date7 October 2016
Primary completion31 March 2020
Estimated completion2 April 2020
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 8 to 14, any sex, with Pediatric Pulmonary Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Physical activity is an important factor in understanding how diseases can affect a child. Decreases in physical activity are sometimes the first thing that happens before a child is diagnosed with a disease. When a child sees their doctor, that visit reflects a single point in time. It does not capture how a child feels during the days in between visits to their doctor. This study plans to use special monitors called actigraphs to collect information about physical activity in children with a type of disease called pulmonary hypertension. This study will measure how active these children are and compare their activity to clinical information and to actigraphy measurements in children without pulmonary hypertension.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Actigraphy Study Endpoints to Reduce Sample Size and Facilitate Drug Development for Pediatric Pulmonary Arterial Hypertension.
    Sun H, Stockbridge N, Ivy DD, Clark J, et al · · 2025 · cited 1× · PMID 39489285 · DOI 10.1016/j.jpeds.2024.114383

Verify or expand the search:

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02909608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing